Application of Curdlan to Controlled Drug Delivery. II. in Vitro and in Vivo Drug Release Studies of Theophylline-Containing Curdlan Tablets

27Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Tablets (300mg) having two different surface areas were prepared from spray-dried particles of curdlan (100mg)/theophylline (200mg). Drug release from the tablets was studied in vitro and in vivo. The in vitro drug release from a tablet with a larger surface area (Tab L) was faster than that with a smaller one (Tab S). The water uptake of Tab L was larger than that of Tab S, probably due to the difference in the tablets' surface areas. However, the water uptake was not a rate-determining step for the drug release from curdlan tablets containing a large amount of theophylline. A straight line was obtained when release % was plotted vs. time. The slope of each curve was calculated as 0.59 for Tab L and 0.58 for Tab S. This indicates that the release mechanism is non-Fickian diffusion controlled. In addition, the curdlan tablets or theophylline powder were administered orally to 5 healthy volunteers, and saliva concentrations of theophylline were determined. Each saliva concentration was converted to plasma concentration using the saliva to plasma ratio of the drug in each subject. The AUC of Tab L was nearly the same as that of powder, while the AUC of Tab S was smaller than that of powder. The mean residence times (MRTs) of theophylline powder, Tab S and Tab L were 11.1±1.5, 25.4±6.3 and 17.1±1.5h (N=4-5, mean±S.D.), respectively. The mean dissolution times (MDTs) of Tab L in vivo and Tab S in vivo were 5.0±2.1 (N=5, mean±S.D.) and 13.9±5.4h (N=4, mean±S.D.), respectively. On the other hand, the MDTs of Tab L in vitro and Tab S in vitro were 4.8 and 11.2h, respectively. In vivo drug release was very similar to in vitro drug release in both tablets. The lower bioavailability of Tab S suggested that the drug release had not been completed during the gastrointestinal transit period. Tab L would thus be a better controlled release form than Tab S. © 1995, The Pharmaceutical Society of Japan. All rights reserved.

References Powered by Scopus

A simple equation for description of solute release II. Fickian and anomalous release from swellable devices

3777Citations
N/AReaders
Get full text

The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time

555Citations
N/AReaders
Get full text

Release mechanisms in gelforming sustained release preparations

231Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Main properties and current applications of some polysaccharides as biomaterials

862Citations
N/AReaders
Get full text

Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin

272Citations
N/AReaders
Get full text

Recent advances in curdlan biosynthesis, biotechnological production, and applications

128Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kanke, M., Katayama, H., & Nakamura, M. (1995). Application of Curdlan to Controlled Drug Delivery. II. in Vitro and in Vivo Drug Release Studies of Theophylline-Containing Curdlan Tablets. Biological and Pharmaceutical Bulletin, 18(8), 1104–1108. https://doi.org/10.1248/bpb.18.1104

Readers' Seniority

Tooltip

Researcher 2

50%

Professor / Associate Prof. 1

25%

PhD / Post grad / Masters / Doc 1

25%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 2

40%

Medicine and Dentistry 1

20%

Biochemistry, Genetics and Molecular Bi... 1

20%

Linguistics 1

20%

Save time finding and organizing research with Mendeley

Sign up for free